Alzheimer’s disease (AD) affects over five million Americans today. Experts project that number will triple by the year 2050.

AD is progressive, eventually impacting the abilities to recognize close family members, regulate mood and judgment, motor function, understand language, and engage in activities of daily living.

The most significant risk factors for the disease, in addition to biological aging, are family history and genetics. There is no cure for Alzheimer’s.*

Progress in AD Research

Scientists are studying every aspect of the disease to better understand how intrinsic biological aging, genetics, environment, and lifestyle factors influence its development and progression. Such research has the potential to lead to rational modes of prevention, early diagnosis, and effective treatment. MetLife Award winners are continuing to make significant contributions towards those goals.

Here are only a few selected examples, many of which have led to MetLife Awards:

Each of these findings—like all the research supported by MetLife Foundation Awards for Medical Research—brings us closer to a cure.

For more information:

Contact the National Institute on Aging for more information about these studies and additional resources about Alzheimer's disease at 1-800-438-4380 or visit www.nia.nih.gov/Alzheimers.

*Information about Alzheimer's disease courtesy of the Alzheimer's Association.

Additional Links
Helpful Downloads
View more Resources »